← back to search

M. Alan Brookhart

Amgen (United States) · US
🔎 Find collaborators in Statistics and Probability · Economics and Econometrics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Statistics and Probability · Economics and Econometrics
Research interest
Research focused on Observational study and Comparability, with related work in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Population, Narrative review. Notable publications include 'Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma', 'School Masking Policies and Secondary SARS-CoV-2 Transmission', and 'Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population'.
h-index
citations
224
works
7
NIH funding
primary concept
email

Recent publications

Pragmatic considerations for negative control outcome studies to guide non‐randomized comparative analyses: A narrative review
Pharmacoepidemiology and Drug Safety 2023cited by 28position: middledoi
Utilization and Impact of Symptomatic and Exposure SARS-CoV-2 Testing in K-12 Schools
PEDIATRICS 2023cited by 6position: middledoi
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
Blood 2022cited by 59position: middledoi
School Masking Policies and Secondary SARS-CoV-2 Transmission
PEDIATRICS 2022cited by 53position: middledoi
Negative controls to detect uncontrolled confounding in observational studies of mammographic screening comparing participants and non-participants
International Journal of Epidemiology 2020cited by 25position: middledoi
Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United States
Pharmacoepidemiology and Drug Safety 2020cited by 21position: lastdoi
Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population
Journal of the American Society of Nephrology 2019cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Brian D. Bradbury · Amgen (United States)3 papers (2019–2023)Jennifer E. Schuster · Children's Mercy Hospital2 papers (2022–2023)David T. Gilbertson · University of Minnesota, Twin Cities2 papers (2019–2023)Jennifer L. Goldman · University of Kansas2 papers (2022–2023) · 2 papers (2022–2023)Sara N. Levintow · Amgen (United States)2 papers (2020–2023)Timothy L. Lash · Emory Healthcare2 papers (2020–2023) · 2 papers (2022–2023)Kanecia O. Zimmerman · University of Colorado Denver2 papers (2022–2023)Kenneth J. Rothman · Boston University2 papers (2019–2023)Daniel K. Benjamin · Duke University2 papers (2022–2023)Tyler Walsh · Nationwide Children's Hospital1 papers (2023–2023)Bradley Saul · Tufts University1 papers (2020–2020)Hervé Ghesquières · Université Claude Bernard Lyon 11 papers (2022–2022)Paul Muntner · Diagnostics for the Real World (United States)1 papers (2023–2023)Susan M. Kiene · Brown University1 papers (2023–2023)Véra Ehrenstein · Amgen (United States)1 papers (2020–2020)Amy Falk · Medical College of Wisconsin1 papers (2022–2022) · 1 papers (2022–2022)Sabrina M. Butteris · Medical College of Wisconsin1 papers (2022–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Statistics and Probability · Economics and Econometrics →